KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biolife Solutions (BLFS) Operating Expenses (2016 - 2025)

Biolife Solutions (BLFS) has disclosed Operating Expenses for 16 consecutive years, with -$16.7 million as the latest value for Q4 2025.

  • On a quarterly basis, Operating Expenses fell 66.83% to -$16.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $78.7 million, a 44.25% increase, with the full-year FY2025 number at $78.7 million, up 44.25% from a year prior.
  • Operating Expenses was -$16.7 million for Q4 2025 at Biolife Solutions, down from $28.2 million in the prior quarter.
  • In the past five years, Operating Expenses ranged from a high of $117.1 million in Q2 2022 to a low of -$131.6 million in Q4 2022.
  • A 5-year average of $21.4 million and a median of $32.0 million in 2021 define the central range for Operating Expenses.
  • Peak YoY movement for Operating Expenses: skyrocketed 262.08% in 2021, then plummeted 335.98% in 2022.
  • Biolife Solutions' Operating Expenses stood at $55.8 million in 2021, then plummeted by 335.98% to -$131.6 million in 2022, then skyrocketed by 45.52% to -$71.7 million in 2023, then surged by 86.07% to -$10.0 million in 2024, then crashed by 66.83% to -$16.7 million in 2025.
  • Per Business Quant, the three most recent readings for BLFS's Operating Expenses are -$16.7 million (Q4 2025), $28.2 million (Q3 2025), and $42.1 million (Q2 2025).